Home
Market
BT TV
Reels
Menu
India is importing less pharmaceutical raw materials from China, but the Chinese challenge is far from over.
Indian pharma companies are facing strong headwinds, but they are also exploring every new opportunity to ensure a quick recovery.
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.
Indian pharmaceutical and healthcare companies are on the defensive. Our special report takes you through the headwinds they are facing and how they are reworking the way they make and market medicines.
India's drug exports dipped 0.5 per cent in 2016/17
Technology has the potential to reshape India's healthcare and pharmaceutical sectors.